Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07501039 · ClinicalTrials.gov registry record · Phase 1
A Phase 1 Study of BLKR201 in Healthy Adult Participants
A Phase 1 study, sponsored by Formation Bio.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 128
- Enrollment target
NCT07501039 is a Phase 1 study that is actively recruiting participants, run by Formation Bio. The registered enrollment target is 128 participants.
The verdict
NCT07501039, a Phase 1 study, is actively recruiting participants, sponsored by Formation Bio.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 128 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn if BLKR201 is safe in healthy adults. Researchers will also learn how the body absorbs and processes BLKR201 and how food may affect it. The main questions this study aims to answer are: * Is BLKR201 safe and well tolerated when taken as a single dose or for several days in a row? * How does BLKR201 move through and leave the body? * Does taking BLKR201 with food change how the body absorbs it? Researchers will compare BLKR201 to a placebo (a look-alike tablet that contains no drug) in most parts of the study to see how the drug affects participants. Participants will: * Take BLKR201 or a placebo by mouth * Stay at a clinical research unit for several days during dosing * Give blood and urine samples * Have heart tests, vital signs, and lab tests * Report any side effects In one part of the study, a small group of participants will receive BLKR201 only (no placebo). These participants will also have a sample of spinal fluid collected to measure how much BLKR201 reaches the fluid around the brain and spinal cord.
Interventions
- DRUG Placebo
- DRUG BLKR201
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2026-04-27 |
| Est. Completion | 2027-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07501039
The ClinicalTrials.gov registry entry for NCT07501039 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 128 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Formation Bio, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT07501039 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07501039 about?
NCT07501039 is a clinical study titled "A Phase 1 Study of BLKR201 in Healthy Adult Participants". The goal of this clinical trial is to learn if BLKR201 is safe in healthy adults. Researchers will also learn how the body absorbs and processes BLKR201 and how food may affect it. The main questions this study aims to answer are: * Is BLKR201 safe and well tolerated when taken as a single dose or...
What is the current status of trial NCT07501039?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 128 participants. The study started on 2026-04-27. Estimated completion is 2027-02.
What interventions are being tested in trial NCT07501039?
The interventions under investigation include: Placebo (DRUG), BLKR201 (DRUG).
Who is sponsoring clinical trial NCT07501039?
This trial is sponsored by Formation Bio, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.